| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/25/2012 | CN102327502A Chinese medicament capsule for treating tracheitis |
| 01/25/2012 | CN102327499A Reed rhizome and loguat leaf granules |
| 01/25/2012 | CN102327493A Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases |
| 01/25/2012 | CN102327487A Chinese herbal medicine for treating liver yin deficiency and liver heat lung stimulating cough |
| 01/25/2012 | CN102327457A Chinese herbal medicine for treating yin deficiency lung heat and wind phlegm pharyngalgia |
| 01/25/2012 | CN102327455A Traditional Chinese medicine for treating pediatric bronchitis, bronchial pneumonia and asthma |
| 01/25/2012 | CN102327451A Chinese medicinal composition for treating chronic sinusitis |
| 01/25/2012 | CN102327447A Chinese herbal medicine for treating wind heat dampness and blood stasis toxicity pharyngalgia |
| 01/25/2012 | CN102327402A Composition containing selfheal and blackberry lily and purpose thereof |
| 01/25/2012 | CN102327392A Formula of Chinese medicine for treating viral pneumonia |
| 01/25/2012 | CN102327355A Chinese medicinal preparation for treating exterior cold symptoms of poultry, and preparation method thereof |
| 01/25/2012 | CN102327314A Preparation method of phyllemblic tannin |
| 01/25/2012 | CN102327313A Preparation method of Lianzhi anti-inflammation soft capsule |
| 01/25/2012 | CN102327311A Propolis tablet and production method thereof |
| 01/25/2012 | CN102327310A Preparation method of high-purity platycodon root total saponin |
| 01/25/2012 | CN102327302A Ilex pubescens formula granules and preparation method thereof |
| 01/25/2012 | CN102327299A Process for preparing daphniphyllum calycinum general flavones and total alkaloids simultaneously |
| 01/25/2012 | CN102327285A Formulations decreasing infectivity of pulmonary diseases |
| 01/25/2012 | CN102327269A Solid lipidosome preparation of compound cefaclor medicinal composition |
| 01/25/2012 | CN102327267A Pharmaceutical compositions |
| 01/25/2012 | CN102327244A Ambroxol hydrochloride orally disintegrating tablet and preparation method thereof |
| 01/25/2012 | CN102327225A Tilmicosin liposome injection and preparation method thereof |
| 01/25/2012 | CN102327220A Solid loratadine lipidosome preparation |
| 01/25/2012 | CN102327002A Health-care functional quilt core |
| 01/25/2012 | CN102058767B Chinese medicine for treating senile chronic bronchitis and method for preparing pills thereof |
| 01/25/2012 | CN101991703B Traditional Chinese medicine for treating globus hysteriocus diseases |
| 01/25/2012 | CN101966251B Medicinal composition for preventing and treating bronchial asthma and preparation and application thereof |
| 01/25/2012 | CN101912596B Medicament for treating allergic rhinitis and preparation method thereof |
| 01/25/2012 | CN101904884B Quality detection method for Chinese medicinal compound isatis root granules |
| 01/25/2012 | CN101897719B Medical composite used for treating smoke inhalation lung injury |
| 01/25/2012 | CN101810581B Method for enhancing content uniformity of clenbuterol hydrochloride and application thereof |
| 01/25/2012 | CN101757090B Medicine composite for treating avian infectious bronchitis nephritis as well as preparation method and application thereof |
| 01/25/2012 | CN101704826B Chinese medicinal lilac daphne flower bud diterpene ortho-ester compounds |
| 01/25/2012 | CN101703484B Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection |
| 01/25/2012 | CN101647905B Preparation method of influenze granule for children |
| 01/25/2012 | CN101422564B Traditional Chinese medicine preparation for treating rhinitis |
| 01/25/2012 | CN101332268B Medicine for treating rhinitis, sinusitis |
| 01/25/2012 | CN101152264B Medicament for treating prostate disease and urinary tract infection and method for preparing the same |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101588 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/24/2012 | US8101160 Formulations for use in inhaler devices |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/21/2012 | CA2710701A1 Honey compositions and uses thereof |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012007539A1 Ip receptor agonist heterocyclic compounds |
| 01/19/2012 | WO2012007375A1 Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators |
| 01/19/2012 | WO2012007130A1 Treatment of lung infections by administration of tobramycin by aerolisation |
| 01/19/2012 | WO2012007113A1 Polysaccharide polymer from the seeds of the tamarind tree for use in treating dry cough |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2011141180A8 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011112983A3 Psrp is a protective antigen against pneumococcal infection |
| 01/19/2012 | WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/19/2012 | WO2011109679A3 Inhibitors of 5-lipoxygenase |
| 01/19/2012 | US20120016029 Antagonists of prostaglandin d2 receptors |
| 01/19/2012 | US20120016011 RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/19/2012 | US20120016010 RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/19/2012 | US20120016005 Phagocytic cell delivery of rnai |
| 01/19/2012 | US20120015999 Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
| 01/19/2012 | US20120015994 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors |
| 01/19/2012 | US20120015991 Polycyclic antagonists of lysophosphatidic acid receptors |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015984 Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients |
| 01/19/2012 | US20120015982 Thiazolidinedione analogues |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015963 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| 01/19/2012 | US20120015962 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS |
| 01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 01/19/2012 | US20120015937 Kinase Inhibitors And Their Uses |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015929 Novel compounds as cannabinoid receptor ligands |
| 01/19/2012 | US20120015927 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015923 Use of andrographolide compounds for treating inflammation and airway disorders |
| 01/19/2012 | US20120015922 Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd) |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015901 Methods and preparations for protecting critically ill patients |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014962 Method of inhibiting fibrogenesis and treating fibrotic disease |
| 01/19/2012 | US20120014930 Stem cells for treating lung diseases |
| 01/19/2012 | US20120014929 Stem cells for treating lung diseases |
| 01/19/2012 | US20120012123 Compositions, articles and methods for preventing or reducing tobacco-associated damage |
| 01/19/2012 | CA2805700A1 Pharmaceutical compositions |
| 01/19/2012 | CA2804744A1 Ip receptor agonist heterocyclic compounds |
| 01/19/2012 | CA2803187A1 Treatment of lung infections by administration of tobramycin by aerolisation |
| 01/19/2012 | CA2802641A1 Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators |
| 01/18/2012 | EP2407476A1 Steroid compound |